Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development

Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development - Association of Graves' disease and thymic hyperplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35294

Enrollment

Registered

2008-10-27

Start date

2009-07-15

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymus hyperplasie Hyperthyroidism

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Graves' disease radioactive iodine treatment

Exclusion criteria

Exclusion criteria: use of corticosteroids older than 50 years of age psychiatric diseases pregnancy

Design outcomes

Primary

Measure	Time frame
Presence of thymic hyperplasia.	—

Secondary

Measure	Time frame
Increase of naive T cells in the blood. Increase in TRECs in the blood.	—

Countries

Netherlands

Outcome results